These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Current developments in production and testing of tetanus and diphtheria vaccines. Relyveld EH Prog Clin Biol Res; 1980; 47():51-76. PubMed ID: 7010379 [No Abstract] [Full Text] [Related]
4. [The immunological basis of the administration of DTP-polio vaccine]. Cohen H Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905 [TBL] [Abstract][Full Text] [Related]
5. [Immunogenic value of the diphtheria-tetanus-pertussis trivaccine depending on the quantitative variations of its antigenic components. IV. Immunogenic properties of the pertussis compound]. Andreescu V; Caffé I; Marion M; Pozsgi N; Stănică E; Stoian C; Kranzdorf H Arch Roum Pathol Exp Microbiol; 1970 Sep; 29(3):487-92. PubMed ID: 4328575 [No Abstract] [Full Text] [Related]
6. An approach to establishing diphtheria potency specifications for diphtheria and tetanus toxoid, acellular pertussis vaccine formulations linked to clinical efficacy. Brock B; Mckee B Biologicals; 1999 Jun; 27(2):183. PubMed ID: 10600210 [No Abstract] [Full Text] [Related]
7. Immunogenic activities of diphtheria-tetanus-pertussis trivaccines in relation with their quantitative composition. I. Experimental study on animals. Stanica E; Pozsgi N; Stoian C; Andreescu V; Caffé I; Kranzdorf H; David C Prog Immunobiol Stand; 1967; 3():292-3. PubMed ID: 5379948 [No Abstract] [Full Text] [Related]
8. Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents. Pichichero ME; Blatter MM; Kennedy WA; Hedrick J; Descamps D; Friedland LR Pediatrics; 2006 Apr; 117(4):1084-93. PubMed ID: 16585302 [TBL] [Abstract][Full Text] [Related]
9. Diphtheria-tetanus-pertussis vaccine and diphtheria toxoid electrocardiographic, morphologic and histochemical pattern of the guinea pig heart under the influence of the vaccine. Zóøltowska A; Zóltowska A Arch Immunol Ther Exp (Warsz); 1974; 22(3):327-40. PubMed ID: 4837020 [No Abstract] [Full Text] [Related]
10. Advantages of aluminium hydroxide adsorbed combined diphtheria, tetanus, and pertussis vaccines for the immunization of infants. Butler NR; Voyce MA; Burland WL; Hilton ML Br Med J; 1969 Mar; 1(5645):663-6. PubMed ID: 5774314 [TBL] [Abstract][Full Text] [Related]
11. A quadruple vaccine composed of purified diphtheria toxoid, tetanus toxoid, fractions of pertussis bacteria and inactivated polio virus. Larsson B; Neumüller C; Salenstedt CR; Söderholm J; Tiru M Prog Immunobiol Stand; 1971; 5():513-6. PubMed ID: 4660550 [No Abstract] [Full Text] [Related]
12. Evaluation of the pertussis components of diphtheria-tetanus-pertussis vaccine. Murphy MD; Rasnack J; Dickson HD; Dietch M; Brunell PA Pediatrics; 1983 Feb; 71(2):200-5. PubMed ID: 6296755 [TBL] [Abstract][Full Text] [Related]
13. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults. Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526 [TBL] [Abstract][Full Text] [Related]
14. An antibody induction method in mice for the potency assays of diphtheria and tetanus components in combined vaccines. Maheshwari SC; Sharma SB; Kumar A; Sokhey J J Commun Dis; 1998 Sep; 30(3):139-46. PubMed ID: 10093418 [TBL] [Abstract][Full Text] [Related]
15. Combination of DTP and Haemophilus influenzae type b conjugate vaccines can affect laboratory evaluation of potency and immunogenicity. Redhead K; Sesardic D; Yost SE; Attwell AM; Watkins J; Hoy CS; Plumb JE; Corbel MJ Biologicals; 1994 Dec; 22(4):339-45. PubMed ID: 7779360 [TBL] [Abstract][Full Text] [Related]
16. Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine. Ausiello CM; Lande R; Urbani F; Di Carlo B; Stefanelli P; Salmaso S; Mastrantonio P; Cassone A J Infect Dis; 2000 Jun; 181(6):1989-95. PubMed ID: 10837180 [TBL] [Abstract][Full Text] [Related]
17. A mouse model to estimate the potency of the diphtheria component in combined vaccines. Kreeftenberg JG; van der Gun J; Marsman FR; van Asten JA; Sekhuis VM; Hendriksen CF Dev Biol Stand; 1986; 64():21-4. PubMed ID: 2878846 [TBL] [Abstract][Full Text] [Related]
18. Role of whole-cell pertussis vaccine in severe local reactions to the preschool (fifth) dose of diphtheria-pertussis-tetanus vaccine. Scheifele DW; Bjornson G; Halperin SH; Mitchell L; Boraston S CMAJ; 1994 Jan; 150(1):29-35. PubMed ID: 8275406 [TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses. Halperin SA; King J; Law B; Mills E; Willems P Clin Infect Dis; 1999 May; 28(5):995-1001. PubMed ID: 10452624 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]